Gliclazide MR 80mgTablet
Diabetes & Metabolic

Gliclazide MR 80mg

Gliclazide

Second-generation sulfonylurea with a modified-release formulation providing smooth, sustained insulin secretion throughout the day with minimal hypoglycemia risk due to its glucose-dependent mechanism and antioxidant properties. Demonstrated cardioprotective and renal-protective properties in clinical studies, making it the preferred sulfonylurea in high-risk cardiovascular patients.

Strengths

30mg MR / 60mg MR / 80mg (standard)

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Gliclazide 40mg / Modified Release 80mg
Dosage Form
Tablet
Available Strengths
30mg MR / 60mg MR / 80mg (standard)
Packing
10 tablets/strip
Route of Administration
Oral, with breakfast
Dosage
MR: 30-120mg once daily with breakfast; increase by 30mg every 4 weeks; max 120mg/day (MR) or 320mg/day (standard)
Indications
Type 2 diabetes mellitus (monotherapy or in combination with other antidiabetics)
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C, protected from moisture
Shelf Life
36 months
Side Effects
Hypoglycemia, weight gain, nausea, abdominal pain, diarrhea, constipation; rarely liver enzyme elevations
Precautions
Risk of hypoglycemia; dose reduction in renal/hepatic impairment; avoid in sulfonamide allergy; monitor renal function periodically; take with meals to reduce hypoglycemia risk

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Glimepiride 2mgTablet

Glimepiride 2mg

Glimepiride

Third-generation sulfonylurea that stimulates pancreatic beta-cell insulin secretion via selective SUR1 receptor binding, offering a lower hypoglycemia risk compared to earlier sulfonylureas due to glucose-dependent activity. The most cost-effective oral antidiabetic agent in its class and a cornerstone of type 2 diabetes management in emerging markets.

1mg / 2mg / 3mg / 4mg
Sitagliptin 100mgTablet

Sitagliptin 100mg

Sitagliptin Phosphate

First-in-class DPP-4 inhibitor that amplifies incretin-mediated glucose-dependent insulin secretion while suppressing glucagon, offering glycemic control without weight gain or intrinsic hypoglycemia risk. Once-daily dosing, renal dose adjustment flexibility, and a decade-long cardiovascular safety record make it a globally preferred add-on antidiabetic.

25mg / 50mg / 100mg
Vildagliptin 50mgTablet

Vildagliptin 50mg

Vildagliptin

Selective DPP-4 inhibitor with potent enzyme inhibition that improves glycemic control through enhanced incretin-mediated insulin secretion and suppressed post-meal glucagon release. Widely prescribed as a fixed-dose combination with metformin (Galvusmet) offering convenient dual-mechanism therapy without weight gain.

50mg

Need bulk pricing for Gliclazide MR 80mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote